Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,522,409 papers from all fields of science
Search
Sign In
Create Free Account
S-55746
Known as:
S55746
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Bcl-2 Inhibitor BCL201
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL.
D. Moujalled
,
Diane T. Hanna
,
+23 authors
S. Khaw
Blood Advances
2020
Corpus ID: 219986294
Improving survival outcomes in adult B-cell acute lymphoblastic leukemia (B-ALL) remains a clinical challenge. Relapsed disease…
Expand
2019
2019
Faculty Opinions recommendation of S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.
A. Gilmore
Faculty Opinions – Post-Publication Peer Review…
2019
Corpus ID: 208375061
2019
2019
crystal structure of BCL-2 G101V mutation with S55746
R. Birkinshaw
,
C. Luo
,
P. Colman
,
P. Czabotar
2019
Corpus ID: 181743867
Highly Cited
2018
Highly Cited
2018
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
D. Moujalled
,
Giovanna Pomilio
,
+24 authors
A. Wei
Leukemia
2018
Corpus ID: 52273887
Improving outcomes in acute myeloid leukemia (AML) remains a major clinical challenge. Overexpression of pro-survival BCL-2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE